Literature DB >> 23313187

Radiologic findings of thoracic scoliosis due to giant ganglioneuroma.

Taylan Kara1, Cigdem Oztunali.   

Abstract

A 28-year-old male with scoliosis presented with complaints of dyspnea and vomiting. His medical history revealed a mediastinal ganglioneuroma resection at the age of 2. After the surgery, he had not been followed up until his admission to our hospital. Computed tomography and MRI showed severe scoliosis of the thoracic spine and a paravertebral mass extending from the upper thoracic level to the level of renal arteries. Based on its radiological findings and the patient's history, the tumor was considered to be a recurrent ganglioneuroma. Paravertebral ganglioneuromas may cause progressive scoliosis, and a careful examination for patients with progressive scoliosis is mandatory.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23313187     DOI: 10.1016/j.clinimag.2012.11.003

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  4 in total

Review 1.  Incidental ganglioneuromas: a presentation of 14 surgical cases and literature review.

Authors:  C Spinelli; L Rossi; A Barbetta; C Ugolini; S Strambi
Journal:  J Endocrinol Invest       Date:  2014-12-13       Impact factor: 4.256

2.  Giant Ganglioneuroma of Thoracic Spine: A Case Report and Review of Literature.

Authors:  Yong Huang; Lidi Liu; Qiao Li; Shaokun Zhang
Journal:  J Korean Neurosurg Soc       Date:  2017-05-01

Review 3.  Retroperitoneal ganglioneuroma combined with scoliosis: A case report and literature review.

Authors:  Xiaolu Wang; Lu Yang; Ming Shi; Xuejuan Liu; Ya Liu; Jing Wang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 4.  Thoracolumbar paravertebral giant ganglioneuroma and scoliosis: a case report and literature review.

Authors:  Yihao Yang; Mingyan Ren; Zhongqin Yuan; Kun Li; Zhiping Zhang; Jing Zhang; Lin Xie; Zuozhang Yang
Journal:  World J Surg Oncol       Date:  2016-03-05       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.